Public-private partnerships (PPPs) are established to specifically harness the potential of Big Data in healthcare and can include partners working across the data chain-producing health data, analysing data, using research results or creating value from data. This domain paper will illustrate the challenges that arise when partners from the public and private sector collaborate to share, analyse and use biomedical Big Data. We discuss three specific challenges for PPPs: working within the social licence, public antipathy to the commercialisation of public sector health data, and questions of ownership, both of the data and any resulting intellectual property or products. As a specific example we consider the case of the UK National Health Service (NHS) providing patient data to Google's DeepMind AI program to develop a diagnostic app for kidney disease. This article is an application of the framework presented in this issue of ABR (Xafis et al. 2019). Please refer to that article for more information on how this framework is to be used, including a full explanation of the key values involved and the balancing approach used in the case study at the end. We use four specific values to help analysis these issues: public benefit, stewardship, transparency and engagement. We demonstrate how the Deliberative Framework can support ethical governance of PPPs involving biomedical big data.

Angela Ballantyne

Cameron Stewart

Asian Bioethics Review

亚洲生物伦理学评论 (ABR) 是一份立足亚洲的国际学术期刊，提供一个论坛，就生物伦理学的各个方面，尤其是与该地区相关的方面，表达和交流原创思想。该杂志每季度出版一次，旨在促进亚洲学者或对亚洲感兴趣的学者之间的合作研究，以及更广泛的多文化和多学科生物伦理研究。它将吸引所有致力于生物医学、医疗保健、护理和患者支持、遗传学、法律和治理、卫生系统和政策、科学研究和研究的生物伦理问题的人。 ABR 对生物伦理​​学的新方法、生物医学法律和政策的最新变化、能力建设和专业培训的发展以及来自学生的声音或论文提供分析、观点和见解。该期刊包括文章、研究报告、目标文章、案例评估和评论。它还出版书评和给编辑的信件。 ABR 欢迎来自所有国家的原创论文，尤其是与亚洲有关的论文。 ABR 是新加坡国立大学杨潞龄医学院生物医学伦理中心的旗舰出版物。生物医学伦理中心是世界卫生组织生物伦理学合作中心。

The Asian Bioethics Review (ABR) is an international academic journal focused on various aspects of bioethics, particularly those relevant to the Asian region. Published quarterly, the journal aims to foster collaborative research among scholars in Asia and those interested in the region, while promoting multicultural and multidisciplinary bioethics research. ABR attracts researchers dedicated to issues in biomedicine, healthcare, nursing, patient support, genetics, law and governance, health systems and policy, scientific research, and related bioethical concerns. The journal provides analyses, perspectives, and insights on new approaches to bioethics, the latest developments in biomedical law and policy, capacity building, professional training, and voices or papers from students. ABR includes articles, research reports, target articles, case evaluations, and reviews, as well as book reviews and letters to the editor. The journal welcomes original papers from all countries, especially those related to Asia. ABR is the flagship publication of the Centre for Biomedical Ethics at the Yong Loo Lin School of Medicine, National University of Singapore, which is a World Health Organization Collaborating Centre for Bioethics.

《Asian Bioethics Review》（亚洲生物伦理学评论，ABR）是一份国际学术期刊，专注于生物伦理学的各个方面，特别是与亚洲地区相关的议题。该期刊每季度出版一次，旨在促进亚洲学者及对亚洲感兴趣的研究者之间的合作研究，同时推动多文化和多学科的生物伦理研究。ABR吸引所有关注生物医学、医疗保健、护理、患者支持、遗传学、法律与治理、卫生系统与政策、科学研究及相关生物伦理问题的研究者。期刊提供对生物伦理学新方法、生物医学法律与政策的最新动态、能力建设与专业培训的发展，以及来自学生的声音和论文的分析、观点与见解。ABR刊登文章、研究报告、目标文章、案例评估和评论，同时也出版书评和给编辑的信件。该期刊欢迎来自各国的原创论文，尤其是与亚洲相关的研究。ABR是新加坡国立大学杨潞龄医学院生物医学伦理中心的旗舰出版物，该中心是世界卫生组织生物伦理学合作中心。

Big Data and Public-Private Partnerships in Healthcare and Research

It is demonstrated how the Deliberative Framework can support ethical governance of PPPs involving biomedical big data, using the case of the UK National Health Service providing patient data to Google's DeepMind AI program to develop a diagnostic app for kidney disease.

Big Data and Public-Private Partnerships in Healthcare and Research

ivySCI AI Smartly Parses PDF, Answers Researchers' Questions, and Helps You Understand Papers in Seconds

Journal Info

Category	Quartile
MEDICAL ETHICS	3